Industry: Medical Devices & Consumables
Published Date: 2025-01-13
Pages: 123 Pages
Report ld: 3501841
Request Sample
Customized Report
Automatic Peptide Continuous Synthesizer Market Size(US$)

CAGR 2025-2031
2.6%
Market Size,2031
USD 91.9
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Automatic Peptide Continuous Synthesizer was estimated to be worth US$ 76.9 million in 2024 and is forecast to a readjusted size of US$ 91.9 million by 2031 with a CAGR of 2.6% during the forecast period 2025-2031.
North American market for Automatic Peptide Continuous Synthesizer was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Automatic Peptide Continuous Synthesizer was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Automatic Peptide Continuous Synthesizer was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Automatic Peptide Continuous Synthesizer include Gyros Protein Technologies AB, Büchi AG, Biotage, CEM, CSBio, AAPPTec, Activotec, MultiSynTech, NJ Biopharmaceuticals LLC, Peptide Machines, Inc., etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Automatic Peptide Continuous Synthesizer, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Automatic Peptide Continuous Synthesizer by region & country, by Type, and by Application.
The Automatic Peptide Continuous Synthesizer market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Automatic Peptide Continuous Synthesizer.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Automatic Peptide Continuous Synthesizer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Automatic Peptide Continuous Synthesizer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Automatic Peptide Continuous Synthesizer in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Automatic Peptide Continuous Synthesizer Product Introduction
1.2 Global Automatic Peptide Continuous Synthesizer Market Size Forecast
1.2.1 Global Automatic Peptide Continuous Synthesizer Sales Value (2020-2031)
1.2.2 Global Automatic Peptide Continuous Synthesizer Sales Volume (2020-2031)
1.2.3 Global Automatic Peptide Continuous Synthesizer Sales Price (2020-2031)
1.3 Automatic Peptide Continuous Synthesizer Market Trends & Drivers
1.3.1 Automatic Peptide Continuous Synthesizer Industry Trends
1.3.2 Automatic Peptide Continuous Synthesizer Market Drivers & Opportunity
1.3.3 Automatic Peptide Continuous Synthesizer Market Challenges
1.3.4 Automatic Peptide Continuous Synthesizer Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Automatic Peptide Continuous Synthesizer Players Revenue Ranking (2024)
2.2 Global Automatic Peptide Continuous Synthesizer Revenue by Company (2020-2025)
2.3 Global Automatic Peptide Continuous Synthesizer Players Sales Volume Ranking (2024)
2.4 Global Automatic Peptide Continuous Synthesizer Sales Volume by Company Players (2020-2025)
2.5 Global Automatic Peptide Continuous Synthesizer Average Price by Company (2020-2025)
2.6 Key Manufacturers Automatic Peptide Continuous Synthesizer Manufacturing Base and Headquarters
2.7 Key Manufacturers Automatic Peptide Continuous Synthesizer Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Automatic Peptide Continuous Synthesizer
2.9 Automatic Peptide Continuous Synthesizer Market Competitive Analysis
2.9.1 Automatic Peptide Continuous Synthesizer Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Automatic Peptide Continuous Synthesizer Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Automatic Peptide Continuous Synthesizer as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Fully Automatic
3.1.2 Aemi-automatic
3.1.3 Manual
3.2 Global Automatic Peptide Continuous Synthesizer Sales Value by Type
3.2.1 Global Automatic Peptide Continuous Synthesizer Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Automatic Peptide Continuous Synthesizer Sales Value, by Type (2020-2031)
3.2.3 Global Automatic Peptide Continuous Synthesizer Sales Value, by Type (%) (2020-2031)
3.3 Global Automatic Peptide Continuous Synthesizer Sales Volume by Type
3.3.1 Global Automatic Peptide Continuous Synthesizer Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Automatic Peptide Continuous Synthesizer Sales Volume, by Type (2020-2031)
3.3.3 Global Automatic Peptide Continuous Synthesizer Sales Volume, by Type (%) (2020-2031)
3.4 Global Automatic Peptide Continuous Synthesizer Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Laboratory
4.1.2 University
4.1.3 Research Center
4.2 Global Automatic Peptide Continuous Synthesizer Sales Value by Application
4.2.1 Global Automatic Peptide Continuous Synthesizer Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Automatic Peptide Continuous Synthesizer Sales Value, by Application (2020-2031)
4.2.3 Global Automatic Peptide Continuous Synthesizer Sales Value, by Application (%) (2020-2031)
4.3 Global Automatic Peptide Continuous Synthesizer Sales Volume by Application
4.3.1 Global Automatic Peptide Continuous Synthesizer Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Automatic Peptide Continuous Synthesizer Sales Volume, by Application (2020-2031)
4.3.3 Global Automatic Peptide Continuous Synthesizer Sales Volume, by Application (%) (2020-2031)
4.4 Global Automatic Peptide Continuous Synthesizer Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Automatic Peptide Continuous Synthesizer Sales Value by Region
5.1.1 Global Automatic Peptide Continuous Synthesizer Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Automatic Peptide Continuous Synthesizer Sales Value by Region (2020-2025)
5.1.3 Global Automatic Peptide Continuous Synthesizer Sales Value by Region (2026-2031)
5.1.4 Global Automatic Peptide Continuous Synthesizer Sales Value by Region (%), (2020-2031)
5.2 Global Automatic Peptide Continuous Synthesizer Sales Volume by Region
5.2.1 Global Automatic Peptide Continuous Synthesizer Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Automatic Peptide Continuous Synthesizer Sales Volume by Region (2020-2025)
5.2.3 Global Automatic Peptide Continuous Synthesizer Sales Volume by Region (2026-2031)
5.2.4 Global Automatic Peptide Continuous Synthesizer Sales Volume by Region (%), (2020-2031)
5.3 Global Automatic Peptide Continuous Synthesizer Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Automatic Peptide Continuous Synthesizer Sales Value, 2020-2031
5.4.2 North America Automatic Peptide Continuous Synthesizer Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Automatic Peptide Continuous Synthesizer Sales Value, 2020-2031
5.5.2 Europe Automatic Peptide Continuous Synthesizer Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Automatic Peptide Continuous Synthesizer Sales Value, 2020-2031
5.6.2 Asia Pacific Automatic Peptide Continuous Synthesizer Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Automatic Peptide Continuous Synthesizer Sales Value, 2020-2031
5.7.2 South America Automatic Peptide Continuous Synthesizer Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Automatic Peptide Continuous Synthesizer Sales Value, 2020-2031
5.8.2 Middle East & Africa Automatic Peptide Continuous Synthesizer Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Automatic Peptide Continuous Synthesizer Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Automatic Peptide Continuous Synthesizer Sales Value
6.2.1 Key Countries/Regions Automatic Peptide Continuous Synthesizer Sales Value, 2020-2031
6.2.2 Key Countries/Regions Automatic Peptide Continuous Synthesizer Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Automatic Peptide Continuous Synthesizer Sales Value, 2020-2031
6.3.2 United States Automatic Peptide Continuous Synthesizer Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Automatic Peptide Continuous Synthesizer Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Automatic Peptide Continuous Synthesizer Sales Value, 2020-2031
6.4.2 Europe Automatic Peptide Continuous Synthesizer Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Automatic Peptide Continuous Synthesizer Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Automatic Peptide Continuous Synthesizer Sales Value, 2020-2031
6.5.2 China Automatic Peptide Continuous Synthesizer Sales Value by Type (%), 2024 VS 2031
6.5.3 China Automatic Peptide Continuous Synthesizer Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Automatic Peptide Continuous Synthesizer Sales Value, 2020-2031
6.6.2 Japan Automatic Peptide Continuous Synthesizer Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Automatic Peptide Continuous Synthesizer Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Automatic Peptide Continuous Synthesizer Sales Value, 2020-2031
6.7.2 South Korea Automatic Peptide Continuous Synthesizer Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Automatic Peptide Continuous Synthesizer Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Automatic Peptide Continuous Synthesizer Sales Value, 2020-2031
6.8.2 Southeast Asia Automatic Peptide Continuous Synthesizer Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Automatic Peptide Continuous Synthesizer Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Automatic Peptide Continuous Synthesizer Sales Value, 2020-2031
6.9.2 India Automatic Peptide Continuous Synthesizer Sales Value by Type (%), 2024 VS 2031
6.9.3 India Automatic Peptide Continuous Synthesizer Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Gyros Protein Technologies AB
7.1.1 Gyros Protein Technologies AB Company Information
7.1.2 Gyros Protein Technologies AB Introduction and Business Overview
7.1.3 Gyros Protein Technologies AB Automatic Peptide Continuous Synthesizer Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Gyros Protein Technologies AB Automatic Peptide Continuous Synthesizer Product Offerings
7.1.5 Gyros Protein Technologies AB Recent Development
7.2 Büchi AG
7.2.1 Büchi AG Company Information
7.2.2 Büchi AG Introduction and Business Overview
7.2.3 Büchi AG Automatic Peptide Continuous Synthesizer Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Büchi AG Automatic Peptide Continuous Synthesizer Product Offerings
7.2.5 Büchi AG Recent Development
7.3 Biotage
7.3.1 Biotage Company Information
7.3.2 Biotage Introduction and Business Overview
7.3.3 Biotage Automatic Peptide Continuous Synthesizer Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Biotage Automatic Peptide Continuous Synthesizer Product Offerings
7.3.5 Biotage Recent Development
7.4 CEM
7.4.1 CEM Company Information
7.4.2 CEM Introduction and Business Overview
7.4.3 CEM Automatic Peptide Continuous Synthesizer Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 CEM Automatic Peptide Continuous Synthesizer Product Offerings
7.4.5 CEM Recent Development
7.5 CSBio
7.5.1 CSBio Company Information
7.5.2 CSBio Introduction and Business Overview
7.5.3 CSBio Automatic Peptide Continuous Synthesizer Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 CSBio Automatic Peptide Continuous Synthesizer Product Offerings
7.5.5 CSBio Recent Development
7.6 AAPPTec
7.6.1 AAPPTec Company Information
7.6.2 AAPPTec Introduction and Business Overview
7.6.3 AAPPTec Automatic Peptide Continuous Synthesizer Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 AAPPTec Automatic Peptide Continuous Synthesizer Product Offerings
7.6.5 AAPPTec Recent Development
7.7 Activotec
7.7.1 Activotec Company Information
7.7.2 Activotec Introduction and Business Overview
7.7.3 Activotec Automatic Peptide Continuous Synthesizer Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Activotec Automatic Peptide Continuous Synthesizer Product Offerings
7.7.5 Activotec Recent Development
7.8 MultiSynTech
7.8.1 MultiSynTech Company Information
7.8.2 MultiSynTech Introduction and Business Overview
7.8.3 MultiSynTech Automatic Peptide Continuous Synthesizer Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 MultiSynTech Automatic Peptide Continuous Synthesizer Product Offerings
7.8.5 MultiSynTech Recent Development
7.9 NJ Biopharmaceuticals LLC
7.9.1 NJ Biopharmaceuticals LLC Company Information
7.9.2 NJ Biopharmaceuticals LLC Introduction and Business Overview
7.9.3 NJ Biopharmaceuticals LLC Automatic Peptide Continuous Synthesizer Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 NJ Biopharmaceuticals LLC Automatic Peptide Continuous Synthesizer Product Offerings
7.9.5 NJ Biopharmaceuticals LLC Recent Development
7.10 Peptide Machines, Inc.
7.10.1 Peptide Machines, Inc. Company Information
7.10.2 Peptide Machines, Inc. Introduction and Business Overview
7.10.3 Peptide Machines, Inc. Automatic Peptide Continuous Synthesizer Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Peptide Machines, Inc. Automatic Peptide Continuous Synthesizer Product Offerings
7.10.5 Peptide Machines, Inc. Recent Development
7.11 Protein Technologies, Inc.
7.11.1 Protein Technologies, Inc. Company Information
7.11.2 Protein Technologies, Inc. Introduction and Business Overview
7.11.3 Protein Technologies, Inc. Automatic Peptide Continuous Synthesizer Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Protein Technologies, Inc. Automatic Peptide Continuous Synthesizer Product Offerings
7.11.5 Protein Technologies, Inc. Recent Development
7.12 Intavis AG
7.12.1 Intavis AG Company Information
7.12.2 Intavis AG Introduction and Business Overview
7.12.3 Intavis AG Automatic Peptide Continuous Synthesizer Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Intavis AG Automatic Peptide Continuous Synthesizer Product Offerings
7.12.5 Intavis AG Recent Development
8 Industry Chain Analysis
8.1 Automatic Peptide Continuous Synthesizer Industrial Chain
8.2 Automatic Peptide Continuous Synthesizer Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Automatic Peptide Continuous Synthesizer Sales Model
8.5.2 Sales Channel
8.5.3 Automatic Peptide Continuous Synthesizer Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Automatic Peptide Continuous Synthesizer was estimated to be worth US$ 78.74 million in 2025 and is projected to reach US$ 94 million, growing at a CAGR of 2.6% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 136
USD 3950.00
(Single User License)
The global Automatic Peptide Continuous Synthesizer market was valued at US$ 78.74 million in 2025 and is anticipated to reach US$ 94 million by 2032, at a CAGR of 2.6% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 120
USD 2900.00
(Single User License)
The global Automatic Peptide Continuous Synthesizer market size was US$ 76.9 million in 2024 and is forecast to a readjusted size of US$ 91.9 million by 2031 with a CAGR of 2.6% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 97
USD 4250.00
(Single User License)
The global Automatic Peptide Continuous Synthesizer market is projected to grow from US$ 76.9 million in 2024 to US$ 91.9 million by 2031, at a CAGR of 2.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 159
USD 4900.00
(Single User License)
The global market for Automatic Peptide Continuous Synthesizer was valued at US$ 76.9 million in the year 2024 and is projected to reach a revised size of US$ 91.9 million by 2031, growing at a CAGR of 2.6% during the forecast period.
Published Date: 2025-01-13
Pages: 95
USD 2900.00
(Single User License)
The global Automatic Peptide Continuous Synthesizer market was valued at US$ 73 million in 2023 and is anticipated to reach US$ 88 million by 2030, witnessing a CAGR of 2.6% during the forecast period 2024-2030.
Published Date: 2024-01-12
Pages: 91
USD 2900.00
(Single User License)
The global market for Automatic Peptide Continuous Synthesizer was estimated to be worth US$ 78.74 million in 2025 and is projected to reach US$ 94 million, growing at a CAGR of 2.6% from 2026 to 2032.
Published: 2026-06-16
Pages: 136
The global Automatic Peptide Continuous Synthesizer market was valued at US$ 78.74 million in 2025 and is anticipated to reach US$ 94 million by 2032, at a CAGR of 2.6% from 2026 to 2032.
Published: 2026-04-17
Pages: 120
The global Automatic Peptide Continuous Synthesizer market size was US$ 76.9 million in 2024 and is forecast to a readjusted size of US$ 91.9 million by 2031 with a CAGR of 2.6% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 97
The global Automatic Peptide Continuous Synthesizer market is projected to grow from US$ 76.9 million in 2024 to US$ 91.9 million by 2031, at a CAGR of 2.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 159
The global market for Automatic Peptide Continuous Synthesizer was valued at US$ 76.9 million in the year 2024 and is projected to reach a revised size of US$ 91.9 million by 2031, growing at a CAGR of 2.6% during the forecast period.
Published: 2025-01-13
Pages: 95
The global Automatic Peptide Continuous Synthesizer market was valued at US$ 73 million in 2023 and is anticipated to reach US$ 88 million by 2030, witnessing a CAGR of 2.6% during the forecast period 2024-2030.
Published: 2024-01-12
Pages: 91
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now